TRALOKINUMAB DELIVERY DEVICE

The present embodiments provide for tralokinumab delivery devices that are capable of delivering a relatively large viscous dosage form (for example, a 2 mL volume dosage form rather than a 1 mL dosage form) at a controlled flow rate. Advantageously, these embodiments deliver the required tralokinum...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CLAWSON, Corbin, NARWAL, Rojaramani, JAIN, Meena, HANSON, Ian B, BENTE, Paul F, DOUGHTY, Diane, CICCIARELLI, Nicholas J, DARDANI, Ian P
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CLAWSON, Corbin
NARWAL, Rojaramani
JAIN, Meena
HANSON, Ian B
BENTE, Paul F
DOUGHTY, Diane
CICCIARELLI, Nicholas J
DARDANI, Ian P
description The present embodiments provide for tralokinumab delivery devices that are capable of delivering a relatively large viscous dosage form (for example, a 2 mL volume dosage form rather than a 1 mL dosage form) at a controlled flow rate. Advantageously, these embodiments deliver the required tralokinumab dose to the subject with a generally acceptable level of pain intensity. Les présents modes de réalisation concernent des dispositifs d'administration de tralokinumab pouvant administrer une forme galénique visqueuse relativement importante (par exemple, un volume de forme galénique de 2 ml plutôt qu'un volume de forme galénique de 1 ml) selon un débit contrôlé. Avantageusement, ces modes de réalisations administrent la dose requise de tralokinumab à un sujet présentant un niveau d'intensité de douleur généralement acceptable.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2017139290A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2017139290A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2017139290A13</originalsourceid><addsrcrecordid>eNrjZJAJCXL08ff29Av1dXRScHH18QxzDYoEMsI8nV15GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgaG5obGlkaWBo6ExcaoAAXUh1A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TRALOKINUMAB DELIVERY DEVICE</title><source>esp@cenet</source><creator>CLAWSON, Corbin ; NARWAL, Rojaramani ; JAIN, Meena ; HANSON, Ian B ; BENTE, Paul F ; DOUGHTY, Diane ; CICCIARELLI, Nicholas J ; DARDANI, Ian P</creator><creatorcontrib>CLAWSON, Corbin ; NARWAL, Rojaramani ; JAIN, Meena ; HANSON, Ian B ; BENTE, Paul F ; DOUGHTY, Diane ; CICCIARELLI, Nicholas J ; DARDANI, Ian P</creatorcontrib><description>The present embodiments provide for tralokinumab delivery devices that are capable of delivering a relatively large viscous dosage form (for example, a 2 mL volume dosage form rather than a 1 mL dosage form) at a controlled flow rate. Advantageously, these embodiments deliver the required tralokinumab dose to the subject with a generally acceptable level of pain intensity. Les présents modes de réalisation concernent des dispositifs d'administration de tralokinumab pouvant administrer une forme galénique visqueuse relativement importante (par exemple, un volume de forme galénique de 2 ml plutôt qu'un volume de forme galénique de 1 ml) selon un débit contrôlé. Avantageusement, ces modes de réalisations administrent la dose requise de tralokinumab à un sujet présentant un niveau d'intensité de douleur généralement acceptable.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170817&amp;DB=EPODOC&amp;CC=WO&amp;NR=2017139290A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170817&amp;DB=EPODOC&amp;CC=WO&amp;NR=2017139290A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CLAWSON, Corbin</creatorcontrib><creatorcontrib>NARWAL, Rojaramani</creatorcontrib><creatorcontrib>JAIN, Meena</creatorcontrib><creatorcontrib>HANSON, Ian B</creatorcontrib><creatorcontrib>BENTE, Paul F</creatorcontrib><creatorcontrib>DOUGHTY, Diane</creatorcontrib><creatorcontrib>CICCIARELLI, Nicholas J</creatorcontrib><creatorcontrib>DARDANI, Ian P</creatorcontrib><title>TRALOKINUMAB DELIVERY DEVICE</title><description>The present embodiments provide for tralokinumab delivery devices that are capable of delivering a relatively large viscous dosage form (for example, a 2 mL volume dosage form rather than a 1 mL dosage form) at a controlled flow rate. Advantageously, these embodiments deliver the required tralokinumab dose to the subject with a generally acceptable level of pain intensity. Les présents modes de réalisation concernent des dispositifs d'administration de tralokinumab pouvant administrer une forme galénique visqueuse relativement importante (par exemple, un volume de forme galénique de 2 ml plutôt qu'un volume de forme galénique de 1 ml) selon un débit contrôlé. Avantageusement, ces modes de réalisations administrent la dose requise de tralokinumab à un sujet présentant un niveau d'intensité de douleur généralement acceptable.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAJCXL08ff29Av1dXRScHH18QxzDYoEMsI8nV15GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgaG5obGlkaWBo6ExcaoAAXUh1A</recordid><startdate>20170817</startdate><enddate>20170817</enddate><creator>CLAWSON, Corbin</creator><creator>NARWAL, Rojaramani</creator><creator>JAIN, Meena</creator><creator>HANSON, Ian B</creator><creator>BENTE, Paul F</creator><creator>DOUGHTY, Diane</creator><creator>CICCIARELLI, Nicholas J</creator><creator>DARDANI, Ian P</creator><scope>EVB</scope></search><sort><creationdate>20170817</creationdate><title>TRALOKINUMAB DELIVERY DEVICE</title><author>CLAWSON, Corbin ; NARWAL, Rojaramani ; JAIN, Meena ; HANSON, Ian B ; BENTE, Paul F ; DOUGHTY, Diane ; CICCIARELLI, Nicholas J ; DARDANI, Ian P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2017139290A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>CLAWSON, Corbin</creatorcontrib><creatorcontrib>NARWAL, Rojaramani</creatorcontrib><creatorcontrib>JAIN, Meena</creatorcontrib><creatorcontrib>HANSON, Ian B</creatorcontrib><creatorcontrib>BENTE, Paul F</creatorcontrib><creatorcontrib>DOUGHTY, Diane</creatorcontrib><creatorcontrib>CICCIARELLI, Nicholas J</creatorcontrib><creatorcontrib>DARDANI, Ian P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CLAWSON, Corbin</au><au>NARWAL, Rojaramani</au><au>JAIN, Meena</au><au>HANSON, Ian B</au><au>BENTE, Paul F</au><au>DOUGHTY, Diane</au><au>CICCIARELLI, Nicholas J</au><au>DARDANI, Ian P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TRALOKINUMAB DELIVERY DEVICE</title><date>2017-08-17</date><risdate>2017</risdate><abstract>The present embodiments provide for tralokinumab delivery devices that are capable of delivering a relatively large viscous dosage form (for example, a 2 mL volume dosage form rather than a 1 mL dosage form) at a controlled flow rate. Advantageously, these embodiments deliver the required tralokinumab dose to the subject with a generally acceptable level of pain intensity. Les présents modes de réalisation concernent des dispositifs d'administration de tralokinumab pouvant administrer une forme galénique visqueuse relativement importante (par exemple, un volume de forme galénique de 2 ml plutôt qu'un volume de forme galénique de 1 ml) selon un débit contrôlé. Avantageusement, ces modes de réalisations administrent la dose requise de tralokinumab à un sujet présentant un niveau d'intensité de douleur généralement acceptable.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2017139290A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title TRALOKINUMAB DELIVERY DEVICE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T07%3A46%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CLAWSON,%20Corbin&rft.date=2017-08-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2017139290A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true